03 May 2021

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

03 May 2021 | n=38

  1. Brouillette MJ, Koski L, Forcellino L, Gasparri J, et al.
    Predicting occupational outcomes from neuropsychological test performance in older people with HIV.
    AIDS 2021.

  2. Hung R, Patel N, Fox J, Cosgrove C, et al.
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS 2021.

  3. McCann K, Shah S, Hindley L, Hill A, et al.
    Implications of weight gain with newer antiretrovirals: 10-year predictions of cardiovascular disease and diabetes.
    AIDS 2021.

  4. Hassold N, Baltes V, Martin A, Mechai F, et al.
    Hemorrhagic cystitis from BK virus in a patient with AIDS.
    AIDS 2021;35:999-1001.

  5. Metsu D, Aquilina C, Delobel P, Gandia P, et al.
    Maraviroc exposure is influenced by exogenous thyrotoxicosis.
    AIDS 2021;35:701-703.

  6. Aldredge A, Roth G, Vaidya A, Paula Duarte A, et al.
    Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.
    AIDS 2021;35:524-526.

  7. Cattaneo D, Vinti P, Baldelli S, Fusi M, et al.
    Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.
    AIDS 2021;35:522-524.

  8. Pett SL, Spyer M, Haddow LJ, Nhema R, et al.
    Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
    AIDS 2021;35:585-594.

  9. Stecher C, Linnemayr S.
    Promoting antiretroviral therapy adherence habits: a synthesis of economic and psychological theories of habit formation.
    AIDS 2021;35:711-716.

  10. Erlandson KM, Wu K, Lake JE, Samuels DC, et al.
    Mitochondrial DNA haplogroups and weight gain following switch to INSTI-Based ART.
    AIDS 2020.

  11. Xing Y, Guo Y, Wang L, Li H, et al.
    Identification of two Novel HIV-1 Second-generation Recombinant Forms (CRF01_AE/CRF07_BC) in Hebei, China.
    AIDS Res Hum Retroviruses 2021.

  12. Wang L, Shao C, Lu L, Liu J, et al.
    A longitudinal case study of concurrent infection with Syphilis and HIV during the early phase.
    AIDS Res Hum Retroviruses 2021.

  13. Romano JW, Baum M, Demkovich ZR, Diana F, et al.
    Tenofovir Alafenamide (TAF) for HIV Prevention: Review of the Proceedings from the Gates Foundation Long Acting (LA) TAF Product Development Meeting.
    AIDS Res Hum Retroviruses 2021.

  14. Ye DQ, Ashuro AA, Fan YG, Fu YS, et al.
    The Effect of Rosuvastatin on plasma/serum levels of high sensitivity C-reactive protein, Interleukin-6 and D-dimer in people living with Human Immunodeficiency Virus: a systematic review and meta-analysis.
    AIDS Res Hum Retroviruses 2021.

  15. Pujari S, Gaikwad S, Chitalikar A, Dabhade D, et al.
    AIDS Res Hum Retroviruses 2021.

  16. Ibrahim ME, Glidden DV, Grant RM, Anderson PL, et al.
    Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure Prophylaxis.
    AIDS Res Hum Retroviruses 2021.

  17. Siyan C, Qihua X, Jian W, Xinghua T, et al.
    Effects of artesunate tablet on immune activation and reconstitution among HAART-treated patients with incomplete immune responses.
    AIDS Res Hum Retroviruses 2021.

  18. Koech E, Stafford KA, Mutysia I, Katana A, et al.
    Factors Associated with Loss to Follow-up among Patients Receiving HIV Treatment in Nairobi, Kenya.
    AIDS Res Hum Retroviruses 2021.

  19. Vizcarra P, Cabello A, Moreno A, Vivancos MJ, et al.
    Progression risk in people with HIV and COVID-19: Predictive performance of current risk scores.
    AIDS Res Hum Retroviruses 2021.

  20. Beckwith C, Min S, Manne A, Novitsky V, et al.
    HIV drug resistance and transmission networks among a justice-involved population at the time of community re-entry in Washington D.C.
    AIDS Res Hum Retroviruses 2021.

  21. Low A, Teasdale C, Brown K, Barradas DT, et al.
    Human Immunodeficiency Virus Infection in Adolescents and Mode of Transmission in Southern Africa: A Multinational Analysis of Population-Based Survey Data.
    Clin Infect Dis 2021.

  22. Laws RL, Biraro S, Kirungi W, Gianetti B, et al.
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis 2021.

  23. Dear N, Duff E, Esber A, Parikh A, et al.
    Transient reductions in HIV clinic attendance and food security during the COVID-19 pandemic for people living with HIV in four African countries.
    Clin Infect Dis 2021.

  24. Nightingale S, Dreyer AJ, Saylor D, Gisslen M, et al.
    Moving on from HAND: why we need new criteria for cognitive impairment in people with HIV and a proposed way forward.
    Clin Infect Dis 2021.

  25. Jenny-Avital ER.
    Human Immunodeficiency Virus Guidelines: Are We There Yet?
    Clin Infect Dis 2021;72:510-512.

  26. Fourman LT, Stanley TL, Grinspoon SK.
    Reply to Maurice and Lemoine.
    Clin Infect Dis 2021;72:909.

  27. Westreich D, Jenness SM, Marcus JL.
    To Contact Tracing... and Beyond!
    Clin Infect Dis 2021;72:724-725.

  28. Santos ADS, Oliveira RD, Lemos EF, Lima F, et al.
    Yield, Efficiency and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons.
    Clin Infect Dis 2020.

  29. Popping S, Verwijs R, Cuypers L, Claassen M, et al.
    Transmission of NS5A resistance associated substitutions among men-who-have-sex-with-men recently infected with hepatitis C virus genotype 1a.
    Clin Infect Dis 2020.

  30. Pullen MF, Hullsiek KH, Rhein J, Musubire AK, et al.
    CSF early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials.
    Clin Infect Dis 2020.

  31. Butt AA, Yan P, Aslam S, Abou-Samra AB, et al.
    Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.
    Clin Infect Dis 2019.

  32. Lin KY, Lee YL, Huang SH, Chen GJ, et al.
    Public health intervention strategies to contain hepatitis A outbreak.
    Clin Infect Dis 2019.

  33. Gay CL, Bosch RJ, McKhann A, Moseley KF, et al.
    Suspected Immune-Related Adverse Events with an Anti-PD-1 Inhibitor in Healthy People with HIV.
    J Acquir Immune Defic Syndr 2021.

  34. Pitpitan EV, MacKinnon DP, Eaton LA, Smith LR, et al.
    Using novel approaches to evaluate behavioral interventions: Overlooked significant HIV prevention effects in HPTN 015 Project EXPLORE.
    J Acquir Immune Defic Syndr 2021.

  35. Anderson AM, Tang B, Vaida F, Mcclernon D, et al.
    Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study.
    J Acquir Immune Defic Syndr 2021.

  36. Ly KN, Xing J, Spradling PR.
    Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018.
    J Infect Dis 2021.

  37. Santinelli L, De Girolamo G, Borrazzo C, Vassalini P, et al.
    Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
    J Med Virol 2021.

  38. Castro IM, Ricciardi MJ, Gonzalez-Nieto L, Rakasz EG, et al.
    Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection Against SIVmac239 Acquisition
    J Virol 2021.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

14 June 2021

31 May 2021

24 May 2021

17 May 2021

10 May 2021

03 May 2021

Multidisciplinary Journal Club

  1. Bardia A, Hurvitz SA, Tolaney SM, Loirat D, et al.
    Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
    N Engl J Med. 2021;384:1529-1541.

  2. Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, et al.
    Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score >/= 50.
    J Clin Oncol. 2021 Apr 19:JCO2100174. doi: 10.1200/JCO.21.00174.

  3. Kamran H, Jneid H, Kayani WT, Virani SS, et al.
    Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    JAMA. 2021;325:1545-1555.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016